Literature DB >> 23000912

Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice.

Allisson Freire Bento1, Daniela Ferraz Pereira Leite, Rodrigo Marcon, Rafaela Franco Claudino, Rafael Cypriano Dutra, Maíra Cola, Alessandra Cadete Martini, João B Calixto.   

Abstract

Inflammatory bowel disease (IBD) affects millions of people worldwide but its pathophysiology remains unclear. Therefore, experimental models of colitis have contributed crucially for the understanding of IBD, and also in the investigations for effective therapies. Herein we investigated the kinetics of inflammatory mediator production and cell infiltration during acute and chronic dextran sodium sulfate (DSS)-induced colitis. The induction phases with DSS were characterized by severe disease activity with massive colonic polymorphonuclear infiltration and increased levels of tumor necrosis factor-α (TNF-α), keratinocyte-derived chemokine (CXCL1/KC), interleukin (IL)-17 and vascular adhesion molecule-1 (VCAM-1). Interestingly, in the recovery periods, we found marked increase of anti-inflammatory mediators IL-10, IL-4, transforming growth factor-β (TGF-β) and cyclooxygenase 2 (COX-2) that seems be essential for the resolution of intestinal inflammation. Furthermore, nuclear factor κB (NFκB) and regulatory T cell marker forkhead box P3 (FoxP3) were increased gradually during experimental colitis, demonstrating a discrepant profile response and evident immune disbalance in the chronic phase of intestinal mucosal inflammation. Taken together, these results provide valuable information for studies on DSS-induced colitis and especially for the identification of biomarkers that predict disease course and possible therapeutic interventions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000912     DOI: 10.1016/j.bcp.2012.09.007

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  20 in total

1.  Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli.

Authors:  Enzo Spisni; Maria C Valerii; Luigia De Fazio; Elena Cavazza; Francesca Borsetti; Annamaria Sgromo; Marco Candela; Manuela Centanni; Fernando Rizello; Antonio Strillacci
Journal:  Mol Ther       Date:  2014-11-13       Impact factor: 11.454

2.  Oral tolerance is inducible during active dextran sulfate sodium-induced colitis.

Authors:  Satoshi Ino; Chikara Kohda; Kosuke Takeshima; Hiroki Ishikawa; Tomoko Norose; Toshiko Yamochi; Masafumi Takimoto; Hiroshi Takahashi; Kazuo Tanaka
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

3.  VEGFR-3 blocking deteriorates inflammation with impaired lymphatic function and different changes in lymphatic vessels in acute and chronic colitis.

Authors:  Xiao-Lei Wang; Jing Zhao; Li Qin; Jing-Li Cao
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis.

Authors:  M Elvington; J Schepp-Berglind; S Tomlinson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

5.  Linalyl acetate restores colon contractility and blood pressure in repeatedly stressed-ulcerative colitis rats.

Authors:  You Kyoung Shin; Soonho Kwon; Yu Shan Hsieh; A Young Han; Geun Hee Seol
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

6.  Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice.

Authors:  Luigia De Fazio; Elena Cavazza; Enzo Spisni; Antonio Strillacci; Manuela Centanni; Marco Candela; Chiara Praticò; Massimo Campieri; Chiara Ricci; Maria Chiara Valerii
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway.

Authors:  Lifu Wang; Hui Xie; Lian Xu; Qi Liao; Shuo Wan; Zilong Yu; Datao Lin; Beibei Zhang; Zhiyue Lv; Zhongdao Wu; Xi Sun
Journal:  Theranostics       Date:  2017-08-15       Impact factor: 11.556

8.  Deficient production of reactive oxygen species leads to severe chronic DSS-induced colitis in Ncf1/p47phox-mutant mice.

Authors:  Tiago Rodrigues-Sousa; Ana Filipa Ladeirinha; Ana Raquel Santiago; Helena Carvalheiro; Bruno Raposo; Ana Alarcão; António Cabrita; Rikard Holmdahl; Lina Carvalho; M Margarida Souto-Carneiro
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

9.  Overexpression of GATA-3 in T cells accelerates dextran sulfate sodium-induced colitis.

Authors:  Midori Okamura; Keigyou Yoh; Masami Ojima; Naoki Morito; Satoru Takahashi
Journal:  Exp Anim       Date:  2014

10.  β7-Integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon.

Authors:  A Schippers; M Muschaweck; T Clahsen; S Tautorat; L Grieb; K Tenbrock; N Gaßler; N Wagner
Journal:  Mucosal Immunol       Date:  2015-09-09       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.